Form 4 for BHVN Biohaven Ltd.
Accepted 2024-04-23 00:00:00 ET · period of report 2024-04-22 · accession 0001562180-24-003493 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-23 | 2024-04-22 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $41.00 | +122.0K | 1.79M | +7% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-04-22 | P | A | 121,951 | $41.00 | 1,788,417 | D | — | — | (F1) Represents common shares acquired in an underwritten public offering. |